204 related articles for article (PubMed ID: 30488837)
21. Development of an alpha-fetoprotein and Golgi protein 73 multiplex detection assay using xMAP technology.
Wu Y; Ma J; Wang Y; Zhang Y; Hou Y; Zhang C; Sun H; Sun J; Wang Z; Li N
Clin Chim Acta; 2018 Jul; 482():209-214. PubMed ID: 29630871
[TBL] [Abstract][Full Text] [Related]
22. [Value of combined detection of GP73 and alpha-fetoprotein in diagonosis of hepatocellular carcinoma].
Wu QP; Xie FY; Meng QL; Mu YY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Apr; 26(2):148-9. PubMed ID: 23002561
[TBL] [Abstract][Full Text] [Related]
23. Golgi protein 73(GP73), a useful serum marker in liver diseases.
Liu X; Wan X; Li Z; Lin C; Zhan Y; Lu X
Clin Chem Lab Med; 2011 Aug; 49(8):1311-1316. PubMed ID: 21663469
[TBL] [Abstract][Full Text] [Related]
24. Sublingual vein parameters, AFP, AFP-L3, and GP73 in patients with hepatocellular carcinoma.
Zhao J; Guo LY; Yang JM; Jia JW
Genet Mol Res; 2015 Jun; 14(2):7062-7. PubMed ID: 26125916
[TBL] [Abstract][Full Text] [Related]
25. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.
Gatselis NK; Tornai T; Shums Z; Zachou K; Saitis A; Gabeta S; Albesa R; Norman GL; Papp M; Dalekos GN
World J Gastroenterol; 2020 Sep; 26(34):5130-5145. PubMed ID: 32982114
[TBL] [Abstract][Full Text] [Related]
26. [Clinical significance and diagnostic value of Golgi-protein 73 in patients with early-stage primary hepatocellular carcinoma].
Bao YX; Yang Y; Zhao HR; Mao R; Xiao L; Zhang YF; Aisiker T; Wen H
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):505-8. PubMed ID: 24257301
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.
Ibrahim GH; Mahmoud MA; Aly NM
Mol Biol Rep; 2013 Dec; 40(12):7069-75. PubMed ID: 24186850
[TBL] [Abstract][Full Text] [Related]
28. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
Song X; Wu A; Ding Z; Liang S; Zhang C
Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
[TBL] [Abstract][Full Text] [Related]
29. Combined detection of AFP-L3, GP73 and TIP30 enhances diagnostic accuracy for HBV-related cirrhosis and hepatocellular carcinoma.
Yanming L; Yue C; Wencan C; Liangyin WU; Xijun L; Jiafeng Z; Fengping HE
J Pak Med Assoc; 2019 Sep; 69(9):1279-1286. PubMed ID: 31511712
[TBL] [Abstract][Full Text] [Related]
30. GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review.
Ba MC; Long H; Tang YQ; Cui SZ
Int J Clin Exp Pathol; 2012; 5(9):874-81. PubMed ID: 23119104
[TBL] [Abstract][Full Text] [Related]
31. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis.
Zhou Y; Yin X; Ying J; Zhang B
BMC Cancer; 2012 Jan; 12():17. PubMed ID: 22244200
[TBL] [Abstract][Full Text] [Related]
32. Multiple lectin assays for detecting glyco-alteration of serum GP73 in liver diseases.
Jiang K; Shang S; Li W; Guo K; Qin X; Zhang S; Liu Y
Glycoconj J; 2015 Dec; 32(9):657-64. PubMed ID: 26342810
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Golgi Protein 73 (GP73) as a Potential Biomarkers for Hepatocellular Carcinoma.
Shaker MK; Attia FM; Hassan AA; Shedid MM; Aboelmagd MA; Faisal AS
Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776730
[TBL] [Abstract][Full Text] [Related]
34. [Survey of the serum hepatocellular carcinoma marker Golgi glycoprotein (GP73) among Qidong residents and correlation analysis to outcome at two-year follow-up].
Chen JG; Zhu YR; Lu WZ; Zhang YH; Lu JH
Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):780-4. PubMed ID: 23207341
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic value and clinical significance of the Golgi protein-73 in hepatocellular carcinoma].
Shi QF; Pan XD; Zhang WG; Shao WF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):480-2. PubMed ID: 23627036
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
Hu B; Tian X; Sun J; Meng X
Int J Mol Sci; 2013 Dec; 14(12):23559-80. PubMed ID: 24317431
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of fucosylated GP73 in the differential diagnosis of hepatocellular carcinoma.
Zhao Y; Zhang L; Huo L; Pei L; Li Q; Li H; Jin L
Int J Biol Markers; 2018 Nov; 33(4):439-446. PubMed ID: 30238841
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI
Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a magnetic particles-based chemiluminescence enzyme immunoassay for Golgi protein 73 in human serum.
Liu X; Wan X; Lu S; Zhang L; Yu S; Lu X
Clin Chim Acta; 2015 May; 445():54-9. PubMed ID: 25801213
[TBL] [Abstract][Full Text] [Related]
40. The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma.
Li B; Li B; Guo T; Sun Z; Li X; Li X; Wang H; Chen W; Chen P; Mao Y
Biomed Res Int; 2017; 2017():5358615. PubMed ID: 28540298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]